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Suppressor of Cytokine Signaling-1 Is Essential
for Suppressing Dendritic Cell Activation
and Systemic Autoimmunity
Introduction
Autoimmunity is the result of a break in self-tolerance
involving humoral and/or cell-mediated immune mecha-
nisms. One pathological consequence of a failure in
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In experimental transgenic or gene-knockout mouse
models as well as in human patients, it has been well
established that autoimmune diseases are associatedSummary
with many susceptible genes, some of which are cyto-
kines and chemokines and genes related to cytokineSuppressor of cytokine signaling-1 (SOCS1/JAB) neg-
signal transduction (Wakeland et al., 2001). For example,
atively regulates not only the cytokine-signaling path-
transgenic mice overexpressing IFN in the epidermis
way but also lipopolysaccharide (LPS)-induced mac- develop an inflammatory skin disease resembling cuta-
rophage activation. We found that SOCS1-deficient neous lupus erythematosus (Seery et al., 1997). Deletion
dendritic cells (DCs) were also hyperresponsive to in- of the IFN or IFN receptor genes in several lupus-
terferon- and interleukin-4. To define the role of predisposed mouse strains resulted in a significant re-
SOCS1-deficient DCs in vivo, we generated mice in duction in the occurrence of diseases (Balomenos et
which the SOCS1 expression was restored in T and B al., 1998; Peng et al., 1997; Haas et al., 1998; Schwarting
cells on a SOCS1/ background. In these mice, DCs et al., 1998). A mouse line of mutated gp130, in which
were accumulated in the thymus and spleen and pro- the src homology 2-domain-bearing protein tyrosine
duced high levels of BAFF/BLyS and APRIL, resulting phosphatase (SHP)-2 binding site was disrupted, devel-
in the aberrant expansion of B cells and autoreactive oped a rheumatoid arthritis (RA)-like joint disease (At-
antibody production. SOCS1-deficient DCs efficiently sumi et al., 2002). Therefore, cytokines and genes in-
stimulated B cell proliferation in vitro and autoantibody volved in cytokine signal transduction and regulation
production in vivo. These results indicate that SOCS1 are apparently key factors in the development of autoim-
plays an essential role in the normal DC functions and mune disease.
suppression of systemic autoimmunity. The suppressor of cytokine signaling-1 (SOCS1)
emerged as an important physiological regulator of cyto-
kine responses, including IFN and IFN. SOCS1 is
strongly induced by cytokines and inhibits signal trans-*Correspondence: yakihiko@bioreg.kyushu-u.ac.jp
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duction by suppressing JAK tyrosine kinase activity (Sa- and macrophages. Splenic CD11cDCs but not CD11b
CD11c macrophages (Mφ) from IFN/SOCS1/kamoto et al., 1998; Yasukawa et al., 1999). Analysis of
knockout mice indicates that SOCS1 is indispensable mice expressed higher levels of CD80, CD86, and CD40
than those from IFN/SOCS1/ mice (Figure 1A). Fur-for the negative regulation of IFN (Marine et al., 1999;
Alexander et al., 1999). The critical role of SOCS1 for thermore, IFN induced higher levels of CD86 and CD40
expression in SOCS1-deficient DCs than in SOCS1/lymphoid lineages is also demonstrated by elimination
of neonatal lethality by crossing the SOCS1 deficiency DCs (Figure 1B). Our results suggested that lack of
SOCS1 gene might enhance the ability of DCs to activateonto a Rag2-deficient background (Marine et al., 1999).
Thus, SOCS1 has been thought to play a critical role in naive T cells. To examine this issue, we carried out a
mixed lymphocyte reaction (MLR) in which allogeneiccontrolling T cell activation. However, recently, Mark
et al. reported that T/NKT cell-specific deletion of the BALB/c mouse CD3 cells were stimulated by coculture
with irradiated IFN/ or IFN/SOCS1/ DCs (FigureSOCS-1 gene did not induce lethal multiorgan inflamma-
tion, although it caused enhanced differentiation of thy- 1C). IFN/SOCS1/ DCs stimulated proliferation of
allogeneic T cells more extensively than IFN/ DCs,mocytes toward CD8() T cells and very high percent-
ages of peripheral CD8() T cells with a memory consistent with higher expression of costimulatory mol-
cules in SOCS1-deficient DCs. These data suggest thatphenotype (Chong et al., 2003). This suggests that
SOCS-1 deficiency in other hematopoietic compart- splenic DCs in IFN/SOCS1/ mice were hyperacti-
vated in vivo and hyperresponsive to IFN.ments in addition to T/NKT cells is required for the lethal-
ity observed in SOCS1/ mice. We and others have
found that SOCS1 also plays an essential role in the Lymphocyte-Specific Expression of SOCS1
regulation of macrophage activation by regulating TLR in a SOCS1/ Background Prevented
signaling (Kinjyo et al., 2002; Nakagawa et al., 2002). Neonatal Death in SOCS1/ Mice
Although the precise molecular mechanism is not clear, Although IFN/SOCS1/ showed inflammatory dis-
SOCS1/ macrophages produce larger amounts of in- eases, it takes 6 to 12 months for the onset of the dis-
flammatory cytokines in response to lipopolysaccharide eases (Metcalf et al., 2002), probably because of the
(LPS), and the LPS tolerance is severely impaired. Thus, absence of IFN. In attempts to clarify the nature of
SOCS1 potentially regulates not only adaptive immunity SOCS1-deficient DCs, we generated transgenic mouse
but also innate immunity by suppressing hyperactivation expressing SOCS1 in T and B cells with a Lck proximal
of macrophages and DCs. promoter and an E enhancer, and these Tg mice were
To study the role of SOCS1 in autoimmunity, we exam- crossed into SOCS1/ genetic background (SOCS1/Tg
ined the DC function in IFN/ SOCS1 mice. SOCS1- mice). We established several SOCS1 Tg lines and chose
deficient DCs were already activated and more sensitive one line in which T cells expressed relatively low levels
to IFN and IL-4 than wild-type DCs. We generated of the SOCS1 protein, since overexpression of SOCS1
transgenic mouse expressing SOCS1 in T and B cells in T cells led to immunodeficiency (Fujimoto et al., 2000).
but not in DCs driven by a Lck proximal promoter and Expression levels of the transgenic SOCS1 protein in
an E enhancer on SOCS1/ background (SOCS1/Tg T cells were approximately 5–10 times higher than those
mice). These mice developed systemic autoimmune-like of the endogenous SOCS1 protein in thymic T cells (Fig-
diseases with hypergammaglobulinemia and an in- ure 2A). However, we found no abnormalities in thymic
crease of anti-dsDNA antibodies. We found that SOCS1- differentiation of T cells and activation markers’ expres-
deficient DCs produced a large amount of BAFF/BLyS, sion of splenic T cells in the Tg mice (Supplemental
a newly identified B cell growth and differentiation factor Figure S1 [http://www.immunity.com/cgi/content/full/
that has been implicated in systemic autoimmune dis- 19/3/437/DC1]). Unlike SOCS1/ mice, splenic T cells
eases. These phenotypes are reminiscent of certain hu- did not show an activated phenotype as determined
man and murine autoimmune disorders and suggest by CD44 and CD62L expression levels (Supplemental
that dysregulation of B cell growth-factor secretion in Figure S1 and data not shown). Proliferation of B cells
DCs may be a critical element in the chain of events from SOCS1/Tg mice in response to anti-IgM, anti-
leading to autoimmunity. We propose that SOCS1 is an CD40, and LPS, and that of T cells in response to IL-2
important regulator of DCs and functions as a suppres- and IL-4 were normal in SOCS1/ Tg mice (Supple-
sor of a systemic autoimmune disease. mental Figures S2A–S2C [http://www.immunity.com/
cgi/content/full/19/3/437/DC1]). Furthermore, STAT1,
STAT3, and STAT6 phosphorylation in response to IFN,Results
IL6, and IL-4, respectively, was either indistinguishable
or was reduced in splenic B cells from SOCS1/TgSOCS1/ DCs Are Hyperactivated in Response
to Cytokines mice compared with the wild-type B cells (Supplemental
Figure S2D). Similarly, time course of STAT5 and STAT6In wild-type mice, SOCS1 is predominantly expressed
in thymic T cells, and it has been assumed that most of phosphorylation in response to IL-2 and IL-4, respec-
tively, were normal in splenic SOCS/Tg T cells com-the severe inflammatory diseases in SOCS1/ mice are
caused by abnormally activated T or NKT cells (Marine pared with those in SOCS1/ T cells (Supplemental
Figure S2E). These data suggested that the SOCS1/Tget al., 1999; Alexander et al., 1999; Naka et al., 2001).
IFN/SOCS1/ mice survived more than 1 year but B cells as well as T cells restored a normal proliferative
capacity and cytokine responsiveness in vitro.spontaneously developed inflammatory diseases (Met-
calf et al., 2002). The present study investigates the Transgenic SOCS1 was expressed in splenic T and B
cells but not in DCs in SOCS1/Tg mice (Figure 2B).role of SOCS1 in innate- and autoimmunity. First, we
compared the nature of SOCS1/ and SOCS1/ DCs As shown in Figure 2C, SOCS1/Tg mice survived for
Systemic Autoimmune Diseases in SOCS1-Deficient Mice
439
Figure 1. SOCS1-Deficient DCs Are Sponta-
neously Activated and Hypersensitive to IFN
(A) Cells derived from mesenteric lymph
nodes were stained with CD11c, and indi-
cated antibodies and analyzed by three-color
flow cytometry. Indicated markers were ana-
lyzed in lymph node cells gated with CD11c
(upper panels, DC) and CD11cCD11b
(lower panels, Mφ) from IFN/SOCS1/
(shaded thin-line histogram) and IFN/
SOCS1/ mice (bold-line histogram).
(B) Flow cytometric analysis of CD86 and
CD40 expression of splenic DCs cultured in
the presence () or absence () of 10 ng/ml
IFN for 24 hr. Splenic DCs from IFN/
SOCS1/ and IFN/SOCS1/ mice are
shown with shaded thin-line and bold-line
histograms, respectively.
(C) Proliferative capacity of allogenic T cells
from BALB/c mice cocultured with DCs from
IFN/SOCS1/ (open column) and IFN/
SOCS1/ (filled column) mice in MLR assays.
over 6 months in specific pathogen-free (SPF) condi- creased in the spleen of SOCS1/Tg mice (Figures 3A
and 3B). The thymus of SOCS1/Tg mice at 3 weekstions, while all SOCS1/ mice expired within 3 weeks
of birth. This is likely due to substantial prevention of of age was apparently normal in CD4CD8 populations
(data not shown). However, at 8–10 weeks of age, asevere hepatitis in SOCS1-deficient mice (Figure 2D).
dramatic decrease in CD4CD8 double-positive (DP)
T cells and a marked increase in CD4 and CD8 single-Increased Accumulation of DCs in the Thymus
and Spleen of SOCS1/Tg Mice positive (SP) T cells and CD4CD8 double-negative
(DN) T cells were observed in SOCS1/Tg mice (FigureNext, we examined proportional changes of DC in the
spleen and thymus. The population and number of 3C). In our FACS analysis, most of the DN population
was found to be B220CD19 B cells and maturemature CD11bCD11c DCs as well as of CD11b
CD11cB220 plasmacytoid DCs were significantly in- CD11cCD11b DCs (Figures 3D and 3E). Most of the
Immunity
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Figure 2. Survival and Feature of SOCS1/Tg Mice
(A) Expression of endogenous SOCS1 and transgenic Myc-tagged SOCS1 in thymocytes from indicated mice. Freshly isolated T cells (1 
106) were lysed and subjected to Western blotting with anti-SOCS1 and anti-STAT5b antibodies.
(B) Expression of transgenic Myc-tagged SOCS1 in splenic T and B cells and bone marrow-derived DCs and macrophages from SOCS1/Tg
mice.
(C) Survival curves of combined male and female SOCS1/, SOCS1/, and SOCS1/Tg mice under SPF conditions. n  number of mice
surveyed in each group.
(D) Improvement of severe hepatitis in SOCS1/ by expressing SOCS1 in T and B cells. Sections of liver from SOCS1/, SOCS1/, and
SOCS1/Tg mice were subjected to staining with hematoxylin-eosin (H.E.). Original magnification, 200.
DCs in the thymus of SOCS1/Tg expressed readily gravis (Christensson et al., 1988), as well as SLE-mouse
models, such as BWF1 and MRL-lpr/lpr mice (Ishikawadetectable amounts of MHC class II molecules, thus
indicating that these DCs were mature and activated et al., 2001; Usui et al., 1996).
(Figure 3F). Immunohistochemical staining revealed that
B cells accumulated as follicles, although DCs were SOCS1-Deficient DCs from SOCS1/Tg Mice
Are Hypersensitive to IL-4 and IFNdispersed (Figure 3G). Abnormal B cell and DC accumu-
lation in the thymus has been reported as a characteris- Next, we compared maturation of DCs and macro-
phages in SOCS1/Tg mice. As shown in Figure 4A,tic feature of human autoimmune diseases, myasthenia
Systemic Autoimmune Diseases in SOCS1-Deficient Mice
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Figure 3. Characterization of DCs in SOCS/Tg Mice
(A and B) Spleen cells from SOCS1/ or SOCS1/Tg mice were stained with CD11b, CD11c, and B220 and analyzed by three-color flow
cytometry. To determine the population of plasmacytoid DC, cells gated with CD11b-negative populations were analyzed for CD11c and B220
expression in (B).
(C–F) Thymocytes from SOCS1/ and SOCS1/Tg were analyzed for the expression of CD4 and CD8 (C), B220 and CD19 (D), CD11b and
CD11c (E), and CD11c and MHC-class II (F) by flow cytometry.
(G) Immunohistochemical examinations of DCs and B cells on 4% paraformaldehyde fixed thymic sections from SOCS1/ and SOCS1/Tg
mice. 20 m thick sections were stained with anti-CD11c or B220 mAb. Original magnification, 200.
like IFN/SOS1/ mice (Figure 1A), splenic CD11c Next, we confirmed hyperresponsiveness of DCs from
SOCS1/Tg mice to cytokines using bone marrow-DCs but not CD11bCD11c macrophages (Mφ) from
SOCS1/Tg mice expressed higher levels of CD80, derived DCs (BM-DCs). BM-DCs were expanded in the
presence of GM-CSF, with or without IL-4. The numberCD86, and CD40 than those from wild-type SOCS1/
mice (Figure 4A). This indicates that DCs but not macro- and morphology of BM-DCs from SOCS1/Tg mice did
not differ from those from SOCS1/ mice (data notphages were already activated in SOCS1/Tg mice.
Immunity
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Figure 4. SOCS1/Tg DCs Are Spontaneously Activated In Vivo and Hypersensitive to IL-4 and IFN
(A) FACS analysis of DCs (CD11c gated, upper panel) and macrophages (CD11bCD11c gated, lower panel) derived from mesenteric lymph
nodes of SOCS1/ (shaded thin-line histogram) and SOCS1/Tg mice (bold-line histogram).
(B) Flow cytometric analysis of CD86 and CD40 expression of bone marrow-derived (BM)-DCs cultured in the presence of 5 ng/ml GM-CSF
in the presence () or absence () of 10 ng/ml IL-4 for 7 days. BM-DCs from SOCS1/ are shown with the shaded thin-line histogram, and
BM-DCs from SOCS1/Tg are shown with the bold-line histogram.
(C) IL-4 induced STAT6 phosphorylation and GM-CSF-induced STAT5 phosphorylation in BM-DCs. BM-DCs grown in GM-CSF were stimulated
with either IL-4 or GM-CSF at indicated concentrations for 24 hr. Cell extracts were prepared and immunoblotted with indicated antibodies.
(D) BM-DCs were stimulated with IFN at indicated doses for 24 hr. Total cell lysates were analyzed by immunoblotting with anti-phosphorylated
STAT1 and anti-STAT1 antibodies.
shown). In response to IL-4 and IFN, CD86 and CD40 Furthermore, IL-4-induced STAT6 activation as well as
IFN-induced STAT1 activation was clearly upregulatedexpression on DCs was more markedly enhanced in
SOCS1-deficient DCs than in SOCS1/DCs (Figure 4B). in SOCS1-deficient DCs, while GM-CSF-induced STAT5
Systemic Autoimmune Diseases in SOCS1-Deficient Mice
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activation was normal (Figures 4C and 4D). These data KO mice survived over 1 year (data not shown). However,
we found high levels of anti-dsDNA antibody inclearly indicate that absence of SOCS1 conferred hyper-
responsiveness to IL-4 as well as IFN on DCs. CD28/SOCS1/ mice (Figure 5F). These data suggest
that T cell help may not be necessary for the develop-
ment of anti-dsDNA antibody in SOCS1-deficient mice.SOCS1/Tg Mice at 8–20 Weeks of Age Developed
Systemic Autoimmune Diseases
Next, we examined the immunological abnormalities of Aberrant Production of BAFF/BLyS from DCs
in SOCS1/Tg MiceSOCS1/Tg mice. Although almost all SOCS1/Tg
mice had no growth retardation, about 70% of To investigate molecular mechanisms related to autoim-
munity, we measured BAFF/BLyS, a novel member ofSOCS1/Tg mice developed spontaneous dermatitis
on the tail and/or ear as early as 10 weeks after birth the tumor necrosis factor (TNF) ligand superfamily,
which has been shown to be a DC- and monocyte-(Figure 5A). Swelling of the ankle joint or finger was
observed in about 5% of the mice (Figure 5A). Dermatitis derived B cell growth and differentiation factor and is
implicated in autoantibody production in autoimmunewas more frequently observed in female than in male
mice (90% versus 50%). Almost all SOCS1/Tg mice diseases (MacLennan and Vinuesa, 2002; Mackay and
Browning, 2002; Gross et al., 2000; Litinskiy et al., 2002).displayed gross splenomegaly and lymphadenopathy
(Figure 5A). Increased cellularity of the spleen and lymph Using real time RT-PCR (Figure 6A) and Western blotting
(Figure 6B), we detected BAFF/BLyS. High levels ofnode in SOCS1/Tg mice was confirmed by counting
cell numbers (Figure 5B). Histological analysis of the BAFF/BLyS were detected in the thymus, spleen, and
lymph node of SOCS1/Tg mice, while SOCS1/ (WT)spleen of SOCS1/ mice revealed no or a few poorly
formed germinal centers in B-cell follicles (Figure 5C). mice and SOCS1/Tg (Tg) mice expressed no detect-
able amount of BAFF/BLyS in the thymus and low levelsIn contrast, the spleens of SOCS1/Tg mice manifested
numerous germinal centers, which were stained by pea- in the spleen and lymph node. A significant amount of
BAFF/BLyS was detected in IFN/SOCS1/ mice, butnut agglutinin (PNA) (Figure 5C). Then, we measured
serum immunoglobulin (Ig) levels. All classes of Ig levels the levels were much lower than in SOCS1/Tg mice
(data not shown). To confirm the higher production of(IgM, IgG1, IgG2a, and IgE), except for IgG2b, were
higher in SOCS1/Tg mice than in wild-type (SOCS1/) BAFF/BLyS from SOCS1/Tg DCs, the expression of
BAFF/BLyS was compared using a quantitative real time(Figure 5D) or SOCS1/Tg mice (data not shown) at
10–15 weeks of age. Histological examination of kidneys RT-PCR among splenic DCs (Sp-DCs), bone marrow-
derived DCs (BM-DCs), and peritoneal macrophagesfrom SOCS1/Tg mice over 8 weeks of age revealed
evidence of glomerulonephritis, the glomeruli were (Mφ) (Figure 6C). BAFF/BLyS expression levels were
higher in both splenic and bone marrow-derived DCs,slightly enlarged as a result of focal segmental prolifera-
tion, although proteinuria was not detected in these mice but not in macrophages from SOCS1/Tg mice, than
in the wild-type (WT) mice or SOCS1/Tg (Tg) mice.(Figure 5E). Immunohistochemical staining revealed de-
position of IgG and IgM in the mesangial region and Higher production of BAFF/BLyS was also observed
in splenic DCs from old IFN/SOCS1/ mice, whichalong the capillary walls (Figure 5E). We also observed
significantly high levels of anti-dsDNA antibody (Figure correlates with high anti-dsDNA antibody levels in these
mice (data not shown). We also observed higher produc-5F) and anti-chromatin antibody (data not shown) in
SOCS1/Tg mice. The levels of anti-dsDNA antibody tion of APRIL, which is another TNF-family B cell growth
factor related to BAFF/BLyS (MacLennan and Vinuesa,in SOCS1/Tg mice were similar or a little lower than
those in MRL-lpr/lpr mice. SOCS1/Tg mice showed 2002; Litinskiy et al., 2002), from SOCS1-deficient DCs
but not SOCS1-deficient macrophages (Figure 6D).no increase in levels of anti-dsDNA antibody. Since skin
lesions, glomerulonephritis, hypergammaglobulinemia, To confirm higher production of B cell growth factors
such as BAFF/BLyS and APRIL from SOCS1-deficientand autoantibody production often occur in SLE pa-
tients as well as in SLE-model mice such as MRL-lpr/ DCs, splenic B cells were cocultured with SOCS1/ or
SOCS1/Tg splenic DCs in the absence or presencelpr mice (Wakeland et al., 2001; Chan et al., 1999), these
data suggest that SLE-like systemic autoimmunity oc- of anti-IgM (Figure 6E). The anti-BCR-dependent pro-
liferative response of B cells in the presence ofcurred in SOCS1/Tg mice.
These phenotypes were never observed in SOCS1/Tg DCs was markedly increased compared
with the presence of SOCS1/ DCs (Figure 6E). Condi-IFN/SOCS1/ mice until 6 months after birth, al-
though about 50% of the mice did have skin ulcers after tioned medium of SOCS1/Tg DCs culture also en-
hanced B cell proliferation (data not shown), whereas1 year of age (Metcalf et al., 2002, and data not shown).
IFN/SOCS1/ mice also had no increase in the anti- B cell proliferation was not altered by coculture with
macrophages from SOCS1/Tg mice (SupplementaldsDNA antibody levels at 10–15 weeks of age; however,
we observed high titer of anti-dsDNA antibody in Figure S3A [http://www.immunity.com/cgi/content/full/
19/3/437/DC1]). Furthermore, DCs are shown to induceIFN/SOCS1/ mice after 6 months of age (Figure
5F). These data suggest that IFN plays an important CD40-independent immunoglobulin class switching
through BLyS and APRIL (Litinskiy et al., 2002). We foundprogressive role in these diseases of SOCS1/Tg mice
but is not the sole factor for the disease. To examine that SOCS1-deficient DCs induced higher levels of se-
cretion of IgG1 from B cells compared with WT DCsthe involvement of T cells in autoimmunity in SOCS1-
deficient mice, we generated CD28/SOCS1/ mice, (Figure 6F). To evaluate the contribution of BAFF/BLyS
and APRIL to Ig class switching, we examined the effectsince CD28 on T cells provides a costimulatory signal
necessary for T cell activation. As expected, the double of soluble BCMA and TACI (BCMA-Fc and TACI-Fc)
Immunity
444
Systemic Autoimmune Diseases in SOCS1-Deficient Mice
445
which have been shown to block BLyS and APRIL-stim- from SOCS1/Tg mice were hyperactivated to exoge-
nous IFN (Supplemental Figure S3), little difference wasulated induction of IgG and IgA (Litinskiy et al., 2002).
The increase in the production of IgG1 from B cells observed in the expression of costimulatory molecules
and CD40 between SOCS1/ and SOCS1/ macro-in the presence of SOCS1-deficient DCs was partially
blocked by antagonistic reagents against BAFF/BLyS phages in the spleen (Figures 1A and 4A). Furthermore,
production of BAFF/BLyS and APRIL was not elevatedand APRIL (Litinskiy et al., 2002). The effect of soluble
BCMA and TACI was partial, probably because BAFF/ in SOCS1-deficient macrophages (Figures 6A–6D).
Therefore, we propose that DCs but not macrophagesBLyS and APRIL have multiple receptors and CD40 was
also upregulated in SOCS1-deficient DCs. These data are responsible for the development of autoimmune dis-
eases developed in SOCS1/Tg mice.suggest that stimulatory molecules for B cell prolifera-
tion and class switching were produced to a greater DCs have been shown to directly trigger proliferation,
maturation, and class-switch recombination in B cellsextent in SOCS1/Tg DCs than in SOCS1/ DCs, and
this is consistent with the higher expression of BAFF/ by producing BAFF/BLyS and APRIL (MacLennan and
Vinuesa, 2002; Mackay and Browning, 2002; Gross etBLyS and APRIL in DCs from SOCS1/Tg mice.
To obtain evidence that SOCS1/Tg DCs are directly al. 2000; Litinskiy et al., 2002; Kayagaki et al., 2002;
Moore et al., 1999). Circulating BAFF/BLyS was foundinvolved in autoantibody production in vivo, bone mar-
row-derived DCs from SOCS1/ and SOCS1/Tg mice to be abundant in BWF1 and MRL-lpr/lpr mice during
the onset and progression of lupus-like diseases (Grosswere transferred to C57BL/6 mice, and these mice were
injected with LPS on day 3 after DC reconstitution. The et al., 2000). BAFF/BLyS-transgenic animals also have
elevated serum concentrations of IgM, IgG, IgA, andserum levels of the anti-dsDNA antibody were signifi-
cantly increased by the transfer of DCs, and SOCS1/ IgE, and developed lupus-like diseases (Gross et al.,
2000). Kayagaki et al. (2002) also found that treatmentDCs had stronger effects than SOCS1/ DCs (Figure
6G). Similar results were obtained in case of splenic of BWF1 mice with BR3-Fc, a soluble decoy receptor
for BAFF/BLyS, prevented mortality, the developmentDCs. These data suggest that DCs lacking the SOCS1
gene are aberrantly activated in vivo and secrete large of anti-DNA antibodies, glomerular damage, and pro-
teinuria. Therefore, hyperproduction of BAFF/BLyS fromamounts of BAFF/BLyS, thereby subsequently leading
to autoantibody production from B cells. DCs could account for the development of lupus-like
diseases in SOCS1/Tg mice. Production of BAFF/
BLyS is stimulated by cytokines including IFN (Kaya-Discussion
gaki et al., 2002). It is likely that SOCS1-deficient DCs
produced a larger amount of BAFF/BLyS because ofWe found that SOCS1/Tg mice had more DCs, which
produced higher levels of BAFF/BLyS and APRIL than the hypersensitivity to cytokines. A number of studies
suggested that DCs also play an important role in humanwild-type mice and exhibited systemic autoimmune-like
diseases even at an early age. Since SOCS1/ mice autoimmune diseases, and that cytokines, such as IFN
and IFN, are regulators for DC differentiation and matu-die neonatally, it was impossible to examine the function
of SOCS1 in autoimmunity. The expression of SOCS1 ration (Blanco et al., 2001; Palucka et al., 2002). The
features of SOCS1/Tg DCs clearly support these no-in T and B cells in SOCS1/ mice largely suppressed
the lethal effects of SOCS1-deficiency. Like MRL-lpr/lpr tions that DCs and BAFF/BLyS play an essential role in
systemic autoimmunity.mice and some SLE patients, SOCS1/Tg mice devel-
oped skin lesions, glomerulonephritis, and autoantibody We found that SOCS1, a potent inhibitor of cytokine
signal transduction, is a defense molecule for autoimmu-production (Wakeland et al., 2001). A marked accumula-
tion of B cells and myeloid DCs was found in the nity. This suggests that downregulation of cytokine sig-
naling in DCs is pivotal for suppression of autoimmunitySOCS1/Tg thymus, and DCs from SOCS1/Tg mice
were prone to be activated by IL-4 and IFN in vitro. or suppression of autoreactive T and B cell activation.
DCs have been shown to produce a significant amountOur data suggest that the aberrant function/activation
of DCs is closely linked to SLE-like diseases observed in of IFN and plasmacytoid DCs are a major source of
IFN (Siegal et al., 1999; Cella et al., 1999). Thus, thethe SOCS1/Tg mice. We also examined macrophages,
since macrophages were activated in SOCS1/ mice autoactivation circuit of DCs by IFNs is likely to be impor-
tant for antigen presentation as well as for the activation(Kinjyo et al., 2002). Although macrophages isolated
Figure 5. Lupus-Like Diseases in SOCS1/Tg Mice
(A) Appearance of 10-week-old SOCS1/Tg mouse. Typical skin disorder of the tail and ears, and swelling of fingers, splenomegaly, and
lymphadenopathy in SOCS1/Tg mice are shown.
(B) Dot plot showing absolute numbers of cells in the spleen and inguinal lymph node in SOCS1/ and SOCS1/Tg mice.
(C) Immunofluorescence staining of sections from the spleen of SOCS1/ and SOCS1/Tg mice, with antibodies to IgM and with PNA.
(D) Serum concentrations of Ig isotypes were determined using ELISA in SOCS1/ (open circle; n  8) and SOCS/Tg mice (closed circle;
n  8) at 8 to 12 weeks of age. Each data point is from an individual mouse, and mean values are indicated by horizontal lines.
(E) Sections of kidney from SOCS1/ and SOCS1/Tg mice were subjected either to PAS staining or to immunofluorescence staining with
anti-IgG (IgG) or with anti-IgM (IgM). Original magnification, 200.
(F) Blood samples were obtained from MRL/lpr (n  3), SOCS1/ (n  15), SOCS1/Tg (n  5), SOCS1/Tg (n  10), IFN/SOCS1/
(n  5), IFN/ SOCS1/ (15 weeks, n  8), IFN/SOCS1/ (	25 weeks, n  6), CD28/SOCS1/ (n  3), and CD28/SOCS1/ (n 
6) mice at 8 to 15 weeks of age, and the concentration of antibodies to double-stranded DNA was determined by ELISA at a dilution of 1:100.
Mean values are indicated by horizontal lines. Double asterisk, p  0.01.
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Figure 6. Expression of BAFF/BLyS and APRIL in the Spleen and Thymus of SOCS1/Tg Mice
(A) Quantitative real-time RT-PCR of BLyS in tissues in SOCS1/ (WT), SOCS1/Tg (Tg), and SOCS1/Tg mice.
(B) BAFF/BLyS expression determined by using Western blotting. Extracts of thymus, spleen, and lymph nodes from indicated strain mice
were immunoblotted with anti-BAFF/BLyS or anti-STAT5b.
(C and D) Quantitative real-time RT-PCR analysis of BAFF/BLyS (C) and APRIL (D) mRNA levels in splenic DC (Sp-DC), BM-DC, and peritoneal
macrophages (Mφ). GAPDH was used as a control housekeeping gene.
(E) Proliferation of syngeneic B cells cocultured with the indicated number of -irradiated splenic DCs from SOCS/ and SOCS1/Tg mice.
Irradiated DCs were cultured with 2  105 B cells for 72 hr in the presence or absence of anti-IgM, and cell proliferation was assayed with
BrdU incorporation.
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of T cells. SOCS1 may be an essential negative regulator macrophages are hypersensitive to LPS (Kinjyo et al.,
2002; Nakagawa et al., 2002). However, macrophagesof this autoactivation loop, and breakdown of this sys-
tem probably enhances DC activation and autoimmune may not be responsible for any autoimmune symptom
in our SOCS1/Tg mice, since expression of MHC anddiseases occur. Alternatively, it was recently proposed
that a subset of DCs is also essential to silence poten- costimulators in SOCS1-deficient macrophages was
normal in vivo. From current study, we propose thattially pathogenic self-reactive T cells that have escaped
negative selection in the thymus (Mahnke et al., 2002; SOCS1/ DCs are important players for onset of
SOCS1/ diseases, since SOCS1-deficient DCs can ac-Steinman and Nussenzweig, 2002). Therefore, another
possibility is that SOCS1-deficient DCs do not have such tivate proliferation not only of B cells but also of T cells
(Figure 1C). We also observed that SOCS1/ DCs cantolerizing activity.
Given that the lack of SOCS1 leads to hyperactivation induce cytokine production from T cells more efficiently
than WT DCs (T.H., unpublished data). Our hypothesisof DCs and autoimmunity in mice, it is possible that
reduced expression of SOCS1 is also linked to human will be probed by transferring SOCS1/ T cells and
SOCS1/ DCs into wild-type mice. Such experimentsSLE. The human SOCS1 gene is mapped to chromo-
some 16p13.13, but there is no evident linkage in human may answer this question and further investigations are
underway.systemic autoimmune diseases in this locus (Wakeland
et al., 2001). However, we found that SOCS/ mice also
had increased levels of anti-dsDNA antibody as they Experimental Procedures
aged (T.H. et al., unpublished data). Thus, reduced ex-
Micepression of SOCS1 could be a risk factor of SLE. Reduc-
SOCS1/ mice were previously established (Marine et al., 1999)tion of SOCS1 gene expression may also be possible
and backcrossed onto the C57BL/6 background for at least six
by epigenetic changes. Expression of the SOCS1 gene generations. IFN/SOCS1/ mice generated by crossbreeding
is repressed by DNA methylation in hepatocarcinoma SOCS1/mice and IFN-deficient mice with a C57BL/6 background
(Yoshikawa et al., 2001; Nagai et al., 2002). We reported obtained from the Jackson Laboratory. CD28/ mice were as de-
scribed (Saha et al., 1996). Transgenic (Tg) mice were developed, asthat forced expression of SOCS3 by adenovirus in ankle
described (Hanada et al., 2001) and backcrossed onto the C57BL/6joints drastically reduced the severity of collagen-
background more than four times. SOCS1/Tg mice were gener-induced arthritis, a human rheumatoid arthritis-model
ated by intercrossing between SOCS1/Tg and SOCS1/ mice,
(Shouda et al., 2001). If forced expression of SOCS1 in and littermates of SOCS1/ and SOCS1/Tg were compared.
DCs can reduce SLE-like symptoms, SOCS1 may be a Some mice were generated by crossing between SOCS1/Tg male
candidate target for agonistic biologic agents for auto- mice and SOCS1/ female mice. For immunoglobulin and anti-
dsDNA antibody measurement, age-matched C57BL/6 mice wereimmune diseases.
also used as controls. MRL-lpr/lpr mice were purchased from JapanSOCS-1 deficiency causes aberrant activation of
SLC at 8 weeks of age.T cells and NKT cells, which are proposed as the key
cellular mediators of the SOCS1/ disease (Marine et
Allogeneic MLRal., 1999; Naka et al., 2001). SOCS1 deficiency in the
CD3 T cells from BALB/c mice (haplotype “d”) were coculturedhematopoietic compartment is thought to be sufficient
with -irradiated (3000 rad) spleen dendritic cells from SOCS1/
to cause disease because transfer of SOCS1/ bone and IFN/SOCS1/Tg mice (haplotype “b”) in RPMI 1640 medium
marrow into irradiated Jak3-deficient recipients results with 10% FCS and antibiotics. Cell proliferation was assessed after
in premature lethality (Marine et al., 1999). Removal of 72 hr of culture with the use of a BrdU colorimetric assay (Boehringer
Mannheim), the last 20 hr of culture being performed in the presencelymphocytes by Rag2 deficiency prevents the neonatal
of 10 M BrdU.death of SOCS1/mice (Marine et al., 1999). In addition,
NKT cell depletion reduces the severity of the liver dam-
DC Preparationage in SOCS1/ mice, whereas NKT cell stimulation
Bone marrow-derived DCs (BM-DCs) were prepared from bone mar-accelerates the disease, suggesting that hepatic NKT
row suspensions prepared from femurs and tibias as describedcells mediate the liver disease (Naka et al., 2001). How-
(Lutz et al., 1999). In brief, bone marrow cells were seeded at 2 
ever, surprisingly, mice lacking SOCS1 gene specifically 106 per 100 mm dish in RPMI1640 supplemented with 10% fetal
in NKT and T cells generated by the Cre/LoxP system bovine serum (FBS) in the presence of 10 ng/ml recombinant mouse
GM-CSF (PeproTech) with or without 10 ng/ml IL-4 (PeproTech). Ondo not develop any of the inflammatory pathologies and
day 2, 10 ml of an RPMI1640 medium containing 10 ng/ml GM-CSFneonatal death found in SOCS1/ mice (Chong et al.,
was added to the plates. On days 4, 6, 8, and 10, half of the culture2003). This clearly indicates that SOCS-1 deficiency
supernatant was collected and centrifuged, and the cell pellet wascauses multiple effects in vivo and requires other hema-
resuspended in 10 ml of a fresh RPMI1640 medium containing 5
topoietic cell lineages. One apparent candidate is APC, ng/ml mGM-CSF and returned to the original plate. The 12-day-
because APC plays critical roles in antigen recognition cultured BM-DCs were used for the experiment. Dead cells were
removed by centrifugation in Lympholyte-M (Cedarlane). Flow cyto-by T cells. We and others have shown that SOCS1/
(F) IgG1 production from B cells cocultured with DCs from wild-type (WT-DC) or SOCS1/Tg mice (SOCS1/DC). B cells were cultured for
7 days in the presence of anti-mouse IgM without () or with BCMA-Fc chimera, TACI-Fc chimera, or control Fc proteins. IgG1 levels in the
culture supernatants were determined by ELISA.
(G) DC-induced anti-dsDNA antibody production in vivo. BM-DCs (1  107) from SOCS1/ and SOCS1/Tg mice injected intraperitoneally
into C57BL/6 mice. Mice were injected with 30 g LPS on day 3 after DC reconstitution. Serum samples on days 0, 8, and 15 in each mouse
were analyzed for anti-dsDNA antibody in ELISA. The results were expressed as mean with SD for triplicate samples. Asterisk, p  0.05;
double asterisk, p  0.01.
Immunity
448
metric analyses showed that these DC subsets contained 	95% anti-dsDNA antibodies using anti-dsDNA-mouse ELISA kit (Shiba-
yagi, Tokyo). Sera were applied to the wells at dilutions of 1:100.CD11c cells.
Splenic DCs were purified by the modified procedure of a pre-
viously described protocol (Fukao et al., 2002). In brief, spleens Histopathological and Immunohistochemical Examination
were cut into small pieces and incubated in an RPMI 1640 medium Organs were removed from necropsied animals, fixed in 4% para-
containing 400 U/ml of Collagenase Type III (Worthington Biochemi- formaldehyde, embedded in paraffin, and stained with hematoxylin-
cal) for 20 min. The tissue pieces were minced through a nylon eosin. The sections of kidneys were also stained by periodic acid
mesh. Single cells were harvested, washed twice, and cultured for Schiff (PAS) procedure. Sections (20 m thick) of the thymus were
2 hr to allow the DCs to adhere. Nonadherent cells were removed, stained with biotin-labeled anti-CD11c mAb or biotin-labeled anti-
and adherent DCs were incubated overnight. After this incubation, B220 (BD PharMingen) followed by horseradish peroxidase (HRP)-
floating cells were collected and CD11c DCs were positively se- labeled streptavidin (Dako). To decrease nonspecific staining, avi-
lected using MACS magnetic beads (Miltenyi Biotec). Flow cytomet- din/biotin blocking solution (Vector Laboratories) and normal rabbit
ric analyses showed that these DC subsets contained 	90% serum was used between each step. To detect the deposition of
CD11c cells. IgG and IgM immune complexes at glomeruli, we incubated fixed
sections for 1 hr at room temperature with Alexa488-labeled anti-
mouse IgG or anti-mouse IgM (molecular probes). For two-colorTransfer of DCs into Mice
immunofluorescence staining, fixed sections (20 m thick) of spleen1  107 BM-DCs from SOCS1/ and SOCS1/Tg mice were in-
were incubated for 1 hr at room temperature first with Alexa488-jected intraperitoneally into 8-week-old C57BL/6 mice. Mice were
labeled anti-mouse IgM and biotin-labeled PNA (Vector Labora-injected with 30 g LPS on day 3 after DC administration. Serum
tories). Biotin-labeled PNA was followed by Alexa 546-labeled strep-samples on days 0, 8, and 15 in each mouse were analyzed for anti-
tavidin (Molecular Probes).dsDNA antibody in ELISA.
Reverse Transcription PCR AnalysisB Cell Purification
Thymocytes of SOCS1/Tg mice were stained with FITC-labeledB cell purification was done as described (Miyamoto et al., 2002).
anti-Thy1.2, anti-B220, or anti-CD11c and purified using MACS mag-In brief, single-cell suspensions prepared from spleens were treated
netic beads coupled with anti-FITC antibody. Total cellular RNA wasfor 45 min on ice with antibodies to mouse Thy-1.2 (Serotec) and
isolated from thymus, spleen, or purified various lymphoid cellsthen subjected to lysis for 45 min at 37
C with rabbit low-toxicity
using RNeasy (Qiagen) according to the manufacturer’s instructions.complement (Wako). After removal of dead cells by centrifugation
In some experiments, cells purified using MACS magnetic beadsin Lympholyte-M, the remaining cells were plated on plastic dishes
were then used for RNA preparation. Real-time quantitative PCRfor 1 hr at 37
C to remove adherent macrophages. The purity of the
analysis was performed by using ABI 7000 sequence detector sys-resulting B cell preparations usually exceeded 90% and did not
tem (Applied Biosystems). The following primers were used for BLySdiffer substantially between SOCS1/ and SOCS1/ Tg mice.
and APRIL: BLyS, sense 5-TGCTATGGGTCATGTCATCCA-3, anti-
sense 5-GGCAGTGTTTTGGGCATATTC-3; APRIL, sense 5-TCAB Cell Proliferation and IgG1 Production Assay
CAATGGGTCAGGTGGTATC-3, antisense 5-TGTAAATGAAAGACAPurified B cells (2  105) were cultured in RPMI 1640 medium, 10%
CCTGCACTGT-3. FAM (6-carboxyfluorescein)-labeled probes wereFCS in round bottom 96-well plates (Corning) with or without goat
used as target hybridization probes for BLyS and APRIL: BLyS,F(ab)2 specific for mouse IgM (Jackson Immuno Research) at a
5-AGCCTGGTGACCCTGTTCCGATGTATTC-3; APRIL, 5-TGATCCfinal concentration of 10 g/ml. Cell proliferation was assessed after
TGACCGTGCCTACAATAGCTGC-3. TaqMan probe, forward and72 hr of culture with the use of a BrdU colorimetric assay, the last
reverse primer for GAPDH were obtained from TaqMan Rodent20 hr of culture being performed in the presence of 10 M BrdU.
GAPDH Control Reagents (Applied Biosystems). The RT-PCR reac-For IgG1 production assay, purified B cells (2  105) were cultured
tions were performed by using TaqMan Gold RT-PCR Kit (Appliedfor 7 days in 96-well plates in the presence of 10 g/ml goat F(ab)2
Biosystems) according to the manufacturer’s instructions. The ther-specific for mouse IgM either with 10 g/ml of BCMA-Fc chimera,
mal cycling conditions included 50
C for 2 min and 95
C for 10 min,TACI-Fc chimera, or control Fc proteins (R&D Systems). IgG1 levels
followed by 50 cycles of amplification at 95
C for 15 s and 60
C forin the culture supernatants were determined by ELISA.
1 min for denaturing and annealing, respectively. PCR reactions
were run in triplicate. BLyS and APRIL quantity was normalized byFlow Cytometric Analysis
the level of GAPDH and compared with that in wild-type mice.Thymus, spleen, and lymph node were minced in RPMI1640/10%
FCS and digested with 400 U/ml of collagenase Type III for 20 min
Statistical Analysisat 37
C. The cells were passed through a 50 m nylon mesh. Cells
For statistical analysis, we used Student’s t test, and a 95% confi-were stained with FITC, PE, allophycocyanin (APC), or biotin-conju-
dence limit was taken to be significant, defined as p  0.05.gated mAbs in PBS containing 0.1% NaN3 and 2% FCS. Rat mAbs
specific for mouse CD4 (RM4-5), CD8 (53-6.7), CD11b (M1/70),
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